Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
Status:
Unknown status
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This is an evaluation of the effectiveness of darbepoetin alpha in treating anemia of MDS
patients with an International Prognostic Scoring System (IPSS) score of low or intermediate
1.